Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium

Suggested Citation

Banerjee R., Pal P., Hilmi I., Ghoshal U.C., Desai D.C., Rahman M.M., Dutta U., Mohiuddin S.A., Al Mohannadi M., Philip M., Ramesh G.N., Niriella M.A., De Silva A.P., de Silva H.J., Pisespongsa P., Limsrivilai J., Aniwan S., Nawarathne M., Fernandopulle N., Aye T.T., Ni N., Al Awadhi S., Joshi N., Ngoc P.T.V., Kieu T.V., Nguyen A.D., Abdullah M., Ali E., Zeid A., Sollano J.D., Saberi B., Omar M., Mohsin M.N., Aftab H., Wai T.M., Shastri Y.M., Chaudhuri S., Ahmed F., Bhatia S.J., Travis S.P.L. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium. Journal of Gastroenterology and Hepatology (Australia) Vol.37 No.6 (2022) , 1004-1015. 1015. doi:10.1111/jgh.15801 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/87294

Availability

Collections